This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Toshifumi Kano
Research Associate at Sumitomo Chemical Europe
Speaker

Profile

Mr. Toshifumi Kano is a Research Associate specializing in Process Chemistry at Sumitomo Chemical. He obtained his master's degree in organic chemistry from the Graduate School of Natural Science and Technology, Gifu University, Japan (2015-2017). He began his career at Sumitomo Chemical in 2017, focusing on process development for oligonucleotides. He has gained extensive experience in developing oligonucleotide synthesis, including gRNA, and scaling up to commercial scale under GMP.

Agenda Sessions

  • Improving CRISPR genome editing efficiency by optimized manufacturing methods for high-purity modified gRNAs.

    12:05pm